Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

KHTRF

Knight Therapeutics Inc.

USD

Set alert

Price alert · KHTRF

All alert types
8.09 USD -0.15 -1.82%
As of Oct 30, 2026
8.12 Day range 8.12
4.11 52-week range 8.31
YTD
+85.98%
1 year
+95.88%
Open
8.12
Prev close
8.24
Mkt cap
794.69M
Vol
100
Avg vol
2.18K
EPS
0.11
P/E
73.55
More statistics
Low
8.12
High
8.12

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for KHTRF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.81 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 1
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -111×
FY 2016: 70.9×FY 2017: 70.0×FY 2018: 45.8×FY 2019: 76.0×FY 2020: 22.3×FY 2021: 40.5×FY 2022: -19.8×FY 2023: -32.1×FY 2024: 116×FY 2025: -111×
FY 2016 5y median -19.8× FY 2025
P/S 1.3×
FY 2016: 216×FY 2017: 139×FY 2018: 89.0×FY 2019: 22.4×FY 2020: 3.5×FY 2021: 2.7×FY 2022: 2.0×FY 2023: 1.7×FY 2024: 1.4×FY 2025: 1.3×
FY 2016 5y median 1.7× FY 2025
P/B 0.8×
FY 2016: 1.3×FY 2017: 1.2×FY 2018: 1.1×FY 2019: 1.3×FY 2020: 0.8×FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.8×
FY 2016 5y median 0.7× FY 2025
P/FCF 8.7×
FY 2016: 263×FY 2017: 51.4×FY 2018: -116×FY 2019: 645×FY 2020: -21.5×FY 2021: -3.6×FY 2022: 40.3×FY 2023: 21.2×FY 2024: 105×FY 2025: 8.7×
FY 2016 5y median 21.2× FY 2025
EV/EBITDA 11.0×
FY 2016: -104×FY 2017: -96.7×FY 2018: -225×FY 2019: 34.8×FY 2020: 18.6×FY 2021: 14.3×FY 2022: 23.6×FY 2023: 13.8×FY 2024: 7.4×FY 2025: 11.0×
FY 2016 5y median 13.8× FY 2025
EV/Sales 1.3×
FY 2016: 130×FY 2017: 81.5×FY 2018: 69.4×FY 2019: 20.1×FY 2020: 2.7×FY 2021: 2.5×FY 2022: 2.0×FY 2023: 1.7×FY 2024: 1.3×FY 2025: 1.3×
FY 2016 5y median 1.7× FY 2025
FCF Yield 11.5%
FY 2016: 0.4%FY 2017: 1.9%FY 2018: -0.9%FY 2019: 0.2%FY 2020: -4.7%FY 2021: -27.4%FY 2022: 2.5%FY 2023: 4.7%FY 2024: 1.0%FY 2025: 11.5%
FY 2016 5y median 2.5% FY 2025

Profitability

Gross Margin 33.5%
FY 2016: 73.9%FY 2017: 81.6%FY 2018: 81.6%FY 2019: 56.7%FY 2020: 40.9%FY 2021: 47.4%FY 2022: 47.0%FY 2023: 46.5%FY 2024: 47.0%FY 2025: 33.5%
FY 2016 5y median 47.0% FY 2025
Operating Margin -0.5%
FY 2016: -135.4%FY 2017: -119.6%FY 2018: -140.5%FY 2019: 29.5%FY 2020: -1.7%FY 2021: -2.2%FY 2022: -0.8%FY 2023: -0.9%FY 2024: 2.0%FY 2025: -0.5%
FY 2016 5y median -0.8% FY 2025
Net Margin -1.2%
FY 2016: 312.5%FY 2017: 199.7%FY 2018: 192.6%FY 2019: 30.6%FY 2020: 15.9%FY 2021: 6.4%FY 2022: -10.2%FY 2023: -5.1%FY 2024: 1.2%FY 2025: -1.2%
FY 2016 5y median -1.2% FY 2025
ROE -0.7%
FY 2016: 1.9%FY 2017: 1.7%FY 2018: 2.3%FY 2019: 1.8%FY 2020: 3.6%FY 2021: 1.9%FY 2022: -3.6%FY 2023: -2.3%FY 2024: 0.5%FY 2025: -0.7%
FY 2016 5y median -0.7% FY 2025
ROIC -0.2%
FY 2016: -0.6%FY 2017: -0.8%FY 2018: -1.4%FY 2019: 1.1%FY 2020: -0.3%FY 2021: -0.6%FY 2022: -0.2%FY 2023: -0.3%FY 2024: 0.8%FY 2025: -0.2%
FY 2016 5y median -0.2% FY 2025
ROA -0.5%
FY 2016: 1.9%FY 2017: 1.7%FY 2018: 2.3%FY 2019: 1.1%FY 2020: 3.1%FY 2021: 1.6%FY 2022: -2.8%FY 2023: -1.8%FY 2024: 0.4%FY 2025: -0.5%
FY 2016 5y median -0.5% FY 2025

Growth (YoY)

Revenue 21.1%
FY 2016: 472.8%FY 2017: 45.4%FY 2018: 44.8%FY 2019: 279.7%FY 2020: 320.4%FY 2021: 22.0%FY 2022: 20.6%FY 2023: 11.8%FY 2024: 13.1%FY 2025: 21.1%
FY 2016 FY 2025
Operating Income -129.7%
FY 2016: -171.7%FY 2017: -28.4%FY 2018: -70.0%FY 2019: 179.6%FY 2020: -124.6%FY 2021: -54.8%FY 2022: 54.8%FY 2023: -20.3%FY 2024: 356.0%FY 2025: -129.7%
FY 2016 FY 2025
EPS (diluted) -225.9%
FY 2016: -57.1%FY 2017: -20.0%FY 2018: 41.7%FY 2019: -41.2%FY 2020: 140.0%FY 2021: -45.8%FY 2022: -300.0%FY 2023: 38.5%FY 2024: 126.8%FY 2025: -225.9%
FY 2016 FY 2025
Free Cash Flow 1321.4%
FY 2016: -17.1%FY 2017: 378.3%FY 2018: -141.2%FY 2019: 117.1%FY 2020: -2094.7%FY 2021: -446.2%FY 2022: 108.2%FY 2023: 77.2%FY 2024: -81.5%FY 2025: 1321.4%
FY 2016 FY 2025

Financial Health

Current Ratio 2.4×
FY 2016: 82.0×FY 2017: 56.0×FY 2018: 41.8×FY 2019: 2.0×FY 2020: 4.9×FY 2021: 2.9×FY 2022: 2.8×FY 2023: 3.2×FY 2024: 3.6×FY 2025: 2.4×
FY 2016 5y median 2.9× FY 2025
Quick Ratio 1.6×
FY 2016: 81.9×FY 2017: 56.0×FY 2018: 41.7×FY 2019: 1.8×FY 2020: 4.4×FY 2021: 2.2×FY 2022: 2.1×FY 2023: 2.4×FY 2024: 2.6×FY 2025: 1.6×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: 69.6×FY 2017: 68.2×FY 2018: 63.6×FY 2019: -3.9×FY 2020: -6.1×FY 2021: -1.1×FY 2022: 0.2×FY 2023: 0.3×FY 2024: -0.5×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Interest Coverage -0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 37.8×FY 2020: -1.0×FY 2021: -1.5×FY 2022: -0.4×FY 2023: -0.2×FY 2024: 0.8×FY 2025: -0.2×
FY 2016 5y median -0.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31